Founded
Founded at Saint-Laurent du Var (postal code 06), Horus Pharma obtains its status as a pharmaceutical establishment in 2003. The laboratory focuses its business on distributing third-party products.
“preservative-free"
Horus Pharma solidifies its status as a pioneer in the “preservative-free" market by obtaining the first reimbursement by Social Security for eye drops formulated with hyaluronic acid.
Specialists
Horus Pharma expands its portfolio by incorporating new specialities developed by the laboratory, including medicinal products and medical devices, packaged in preservative-free single-dose units.
Associative
Horus Pharma co-founds and chairs Ophta Biotech, an association that brings together actors in ophthalmology and patient associations in the Mediterranean arc.
Europe
The Export strategy kicks off in Europe with the signing of the first distribution agreements with Germany, Switzerland and Austria. To support its international expansion, Horus Pharma incorporates Edel Pharma, a company specialised in Business Development.
The world
Horus Pharma crosses the Atlantic and launches the distribution of its dermatological aproduct line, Ilast, in the US.
1st subsidiary
The laboratory’s first European subsidiary is founded in 2015 with the creation of Horus Iberica, based in Bilbao, Spain.
3rd subsidiary
The third European subsidiary of the laboratory is established in 2017 in the Netherlands.
